TALENE A YACOUBIAN, M.D.
Neurology at 19 St, Birmingham, AL
License number
Alabama 226848
Category
Neurology
Type
Neurology
License number
Alabama 27465
Category
Neurology
Type
Neurology
Address
Address
619 19Th St SOUTH, Birmingham, AL 35233
Phone
(205) 934-6600
Personal information
See more information about TALENE A YACOUBIAN at radaris.comName
Address
Phone
2018 Beverly Hills Dr, Vestavia, AL 35216
3550 Grandview St, Birmingham, AL 35243
2018 Beverly Hills Dr, Birmingham, AL 35216
Organization information
See more information about TALENE A YACOUBIAN at bizstanding.comTalene Yacoubian MD,PHD
619 19 St S, Birmingham, AL 35249
Industry:
Neurologist
Phone:
(800) 822-8816 (Phone)
Talene Alene Yacoubian
Talene Yacoubian MD
2000 6 Ave S #5, Birmingham, AL 35233
Categories:
Neurology Physicians & Surgeons
Phone:
(205) 996-3679 (Phone)
Professional information
See more information about TALENE A YACOUBIAN at trustoria.com
Dr. Talene A Yacoubian, Birmingham AL - MD (Doctor of Medicine)
Dr. Talene A Yacoubian, Birmingham AL - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Address:
Birmingham
619 19Th St S, Birmingham 35233
(205) 934-9999 (Phone), (205) 975-9694 (Fax)
UAB Health System Neurology
2000 6Th Ave S SUITE 5, Birmingham 35233
(205) 801-8950 (Phone)
619 19Th St S, Birmingham 35233
(205) 934-9999 (Phone), (205) 975-9694 (Fax)
UAB Health System Neurology
2000 6Th Ave S SUITE 5, Birmingham 35233
(205) 801-8950 (Phone)
Certifications:
Neurology, 2006
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Birmingham
619 19Th St S, Birmingham 35233
UAB Health System Neurology
2000 6Th Ave S SUITE 5, Birmingham 35233
University of Alabama Hospital
1802 6Th Ave South, Birmingham 35233
619 19Th St S, Birmingham 35233
UAB Health System Neurology
2000 6Th Ave S SUITE 5, Birmingham 35233
University of Alabama Hospital
1802 6Th Ave South, Birmingham 35233
Education:
Medical School
Duke University School Of Medicine
Graduated: 2001
Brigham and Women's Hospital
Graduated: 2002
Massachusetts General Hospital
Graduated: 2005
Graduated: 2006
University Of Alabama Hospital
Graduated: 2007
Duke University School Of Medicine
Graduated: 2001
Brigham and Women's Hospital
Graduated: 2002
Massachusetts General Hospital
Graduated: 2005
Graduated: 2006
University Of Alabama Hospital
Graduated: 2007
Talene Yacoubian, Birmingham AL
Talene Yacoubian, Birmingham AL
Specialties:
Neurology, Internal Medicine
Work:
The Kirklin Clinic
2000 6Th Ave S, Birmingham, AL 35233
2000 6Th Ave S, Birmingham, AL 35233
Education:
Duke University(2001)
Use Of 14-3-3- Proteins In Treatment And Prevention Of Neurodegeneration
Use Of 14-3-3- Proteins In Treatment And Prevention Of Neurodegeneration
US Patent:
2009018, Jul 23, 2009
Filed:
Nov 7, 2008
Appl. No.:
12/267337
Inventors:
Talene Alene Yacoubian - Birmingham AL, US
David G. Standaert - Birmingham AL, US
David G. Standaert - Birmingham AL, US
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
The present disclosure is directed to methods for treatment and prevention of disease states characterized by a decreased 14-3-3 polypeptide expression or activity. In one embodiment, the present disclosure provides methods for the treatment and/or prevention of Parkinson's disease, neurodegeneration and/or diseases characterized, at least in part, by neurodegeneration, by increasing a 14-3-3 polypeptide activity.
Use Of 14-3-3-Proteins In Treatment And Prevention Of Neurodegeneration
Use Of 14-3-3-Proteins In Treatment And Prevention Of Neurodegeneration
US Patent:
2011018, Jul 28, 2011
Filed:
Mar 29, 2011
Appl. No.:
13/075062
Inventors:
Talene Alene Yacoubian - Birmingham AL, US
David G. Standaert - Birmingham AL, US
David G. Standaert - Birmingham AL, US
Assignee:
THE UAB RESEARCH FOUNDATION - Birmingham AL
International Classification:
C12Q 1/68, G01N 33/53, C12Q 1/26
US Classification:
435 612, 435 71, 435 25, 435 61
Abstract:
The present disclosure is directed to methods for treatment and prevention of disease states characterized by a decreased 14-3-3 polypeptide expression or activity. In one embodiment, the present disclosure provides methods for the treatment and/or prevention of Parkinson's disease, neurodegeneration and/or diseases characterized, at least in part, by neurodegeneration, by increasing a 14-3-3 polypeptide activity.